An early-phase, dose-escalation study of a hypofractionated approach to concurrent chemoradiation using an an adaptive stereotactic ablative radiotherapy (SABR) boost showed promising results in ...

Please provide your email address to receive an email when new articles are posted on . Stereotactic ablative radiotherapy plus immunotherapy improved 4-year EFS by 62%. Female sex and treatment with ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The use of ...

Abemaciclib Plus Fulvestrant in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Final Overall Survival Results From MONARCH 2 ...

Global Incidence of Ovarian Cancer According to Histologic Subtype: A Population-Based Cancer Registry Study Local ablative therapy, such as radiotherapy or surgery, plays a key role in treatment of ...

In this study, the 42-patient population was enrolled from 5 sites in Canada and 1 site in Scotland, and data were gathered from March 7, 2019, to January 12, 2022; all had interstitial lung disease ...

Stereotactic ablative body radiotherapy (SABR) is a safe, noninvasive, and effective strategy for treating primary renal cell cancer (RCC) in patients not suited to undergo surgical resection. At 1 ...

Patients with inoperable kidney cancer saw significant results in local control and cancer-specific survival with stereotactic ablative body radiotherapy. Patients with inoperable kidney cancer ...

A new study showed that stereotactic ablative radiotherapy (SABR) was as effective as surgery at providing long-term benefits to patients with operable early-stage non-small cell lung cancer (NSCLC) ...

SOUTH BEND, Ind. (WSBT) — With every cancer diagnosis comes many questions, including what options the patient has. For those with early-stage lung cancer - there is a highly focused treatment that ...